The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. - Wikidata - awgldk - TriplyDB

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

http://www.wikidata.org/entity/Q33944000

about

Vaccines for preventing typhoid fever Vaccines for preventing typhoid fever A mouse model of Salmonella typhi infection A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies The case for a typhoid vaccine probe study and overview of design elements Vaccines against invasive Salmonella disease: current status and future directions Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections Global trends in typhoid and paratyphoid Fever Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults Salmonella typhi Genomics: Envisaging the Future of Typhoid Eradication.Enteric infections, diarrhea, and their impact on function and development.Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005.A study of typhoid fever in five Asian countries: disease burden and implications for controls.Salmonella enterica serovar typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261.Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children Active immunization in the United States: developments over the past decade.Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?Development of Vi conjugate - a new generation of typhoid vaccine.Updated recommendations for the use of typhoid vaccine--Advisory Committee on Immunization Practices, United States, 2015.Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.Prevention and self-treatment of traveler's diarrhea.

P2860

Q24201238-9DB69AD5-723F-4655-B139-DBDDABC937B4 Q24244406-7A388F4F-C71F-486B-8330-77840266292B Q24610761-C15A66CA-7D7E-43D7-B1D6-E5ED52D6D331 Q24811133-7B0CDE7A-3C83-415E-A159-5855475EB598 Q26746887-3849B28E-91EC-4DE6-A6D7-B1823620F31B Q26747650-1338B49F-A0C0-4E18-A0A0-16001114881B Q26773033-938F2E64-EBE1-4DCC-A7A6-A0EB15CE2687 Q26859432-89C5CAD9-8704-4E2D-A52F-0BA06CBD1D8C Q27007088-CE75BCF7-3D7B-409B-8A8B-671B6B886E51 Q27694492-CB6962DC-4A6E-4F8E-A4B2-ABC926E34FA5 Q28084595-B443D5C6-2B20-4CC7-B2EF-85C994C2F43C Q28267865-E8569760-EF79-455C-86FA-987AB8714946 Q28308143-9AF54CF1-B212-4A1D-B093-6101BEDE71C4 Q28394220-AAFCA06F-D2EB-4DD2-A91F-5D0D164606DF Q28476687-141665ED-4363-4D24-B45D-E25E581D5A90 Q28478975-0D49283D-1753-4DE2-B93F-3423D9413A6A Q28741285-487FF590-4B81-40BD-BD23-B52B53689163 Q28744376-2A95596E-1A41-46A5-96F3-B8C8F448425F Q30234360-5789D561-345F-4B9E-A93F-756770E6BB6E Q30443288-57C07A0B-CCE8-4CB1-B632-A33E84AA489E Q31121277-264BB01B-F56B-4EFD-A6CD-950B0345DACA Q33330938-0E0B8EFC-B805-4071-AF6B-5F31A982C0A4 Q33557755-9F589BC8-BE20-425B-A2D1-41D45ED0C0F3 Q33613531-6173C1A5-EDE4-4A54-B7F3-54C1AE86AD48 Q33613913-1ACDBC5D-8790-4788-A156-FCA36E512FD5 Q33684607-9F16D9D6-CCB3-4C3A-BC20-CF7EA8A95205 Q33773373-5C1B9EAD-C1B5-4D98-9A7A-C0990FB54CD2 Q33797264-7D949345-FAF0-44CF-BB8D-700A26231129 Q33975799-CF465873-754F-4AC3-8247-5C5AAA5EE6AE Q34008449-2BCC0686-4ABA-4F74-99F7-D9B2DD04AFD2 Q34044935-35C80D02-88EA-4E05-82CF-902EBA473902 Q34070619-9F1E7094-B4F9-4802-8F3D-15D1556F91E9 Q34111774-8BA838A1-64CA-48CD-9A63-720D5FEF62F8 Q34179527-6CE877BF-4406-4771-8A1A-E7FE7B5AF958 Q34275116-E7BD9711-6346-4657-ACAF-03471C8ABCF8 Q34334259-EAF6FCD8-C52B-4E97-A444-08683230248C Q34380025-BEC38F65-1852-4429-BE94-F4E3028FD6D6 Q34468771-D213335E-3FB4-49A6-8ABC-3899038359AF Q34760675-C9BA9353-EC50-4F3D-B349-8C5E89AE9246 Q34974972-79FEED0D-046F-4851-9D78-8898F774CA4F

P2860

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

http://www.wikidata.org/entity/Q33944000

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@ast

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@en

type

label

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@ast

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@en

prefLabel

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@ast

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@en

P1433

Q33944000-867572E1-BDEA-4086-B1AF-EF19CB59C0C2

P1476

Q33944000-79CFF11D-D5FC-4734-8009-39BF99F94D79

P2093

Q33944000-02AB1B3F-C81C-4DE9-A98A-1C650EA70436

Q33944000-15CD25F5-F453-4830-A71C-3A85E667C5C7

Q33944000-1AB07508-29D3-47CC-B1CC-172FB95BB76A

Q33944000-3017EA45-C11B-4B19-ACFD-B3833FE569E6

Q33944000-35AE8E42-EF0A-4813-AD6E-2F7B8DC32774

Q33944000-976ADBC6-7421-4285-BC47-BDBDF11E7A59

Q33944000-A7BE679D-0A36-4B2E-8120-B010B4C822B3

Q33944000-B54A40DF-D389-484B-B024-21DB97F1EF95

Q33944000-C7A2B33F-0A24-46DF-8B68-76F33A6EE82A

Q33944000-CF3733E2-99B5-41CD-A0AA-4A677E3F0F9F

P304

Q33944000-6B8BBA63-8E05-4221-AC5C-4C3E4718F925

P31

Q33944000-C86DA762-FEDA-4F50-8C7B-6161E8564E4C

P356

Q33944000-0B46EE2A-FDF2-474A-A226-B3E9818F5761

P407

Q33944000-908E232E-9EAF-472B-BE3A-922BD2CB9AFC

P433

Q33944000-17F08A2C-DDBA-436F-9FF8-5E331300A40D

P478

Q33944000-A0AA5C43-2412-4301-AAB7-893D8760B5A7

P577

Q33944000-822BE4F2-2F5F-474F-BB9F-129044C6ED31

P5875

Q33944000-EB100504-CDA8-4D2D-87B6-F0BC4212E322

P698

Q33944000-80723E2F-A6FB-419F-B008-D70F20B6959D

P356

NEJM200104263441701

P1433

The New England Journal of Medicine

P1476

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

@en

P2093

Bay PV

http://www.w3.org/2001/XMLSchema#string

Bryla DA

http://www.w3.org/2001/XMLSchema#string

Ho VA

http://www.w3.org/2001/XMLSchema#string

Khiem HB

http://www.w3.org/2001/XMLSchema#string

Kossaczka Z

http://www.w3.org/2001/XMLSchema#string

Lin FY

http://www.w3.org/2001/XMLSchema#string

Robbins JB

http://www.w3.org/2001/XMLSchema#string

Schneerson R

http://www.w3.org/2001/XMLSchema#string

Shiloach J

http://www.w3.org/2001/XMLSchema#string

Szu SC

http://www.w3.org/2001/XMLSchema#string

P304

1263-1269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM200104263441701

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

344

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12016454

http://www.w3.org/2001/XMLSchema#string

P698

11320385

http://www.w3.org/2001/XMLSchema#string